Acid Sphingomyelinase Deficiency Market Size is expected to witness a major change in the study period 2019-2032.

PRESS RELEASE
Published March 23, 2023

Acid Sphingomyelinase Deficiency Market Report gives readers a thorough assessment of key market drivers, restraints, prospects, opportunities, restraints, current trends, and technological and industrial breakthroughs that will influence market growth. The detailed market research, industry sector growth and development, and new product introductions covered in this report on the Acid Sphingomyelinase Deficiency Market are of great assistance to the important new commercial players joining the market.

Key highlights of the Acid Sphingomyelinase Deficiency Market Report

  • As per the study by the McGovern et al. (2017), titled “Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD)”, it was reported that the incidence of ASMD is 0.5 per 100,000 births, The study also reported that estimates extrapolated from the results of carrier screening suggest that the true incidence may be higher in select populations.
  • According to the National Organization of Rare Diseases, the exact incidence and prevalence of the disorder is unknown, but has been estimated at 1 in 250,000 individuals in the general population.
  • A study by Escobar et al. titled “Niemann-Pick Disease: An Approach for Diagnosis in Adulthood” (2019), quoted that NPD is diagnosed in 80% of cases under the age of 16 years, in 14% after 20 years of age, and extremely rare in older age, depending on the subtype.

 Discover more about therapies set to grab major Acid Sphingomyelinase Deficiency market share @ Acid Sphingomyelinase Deficiency Market Size

Acid Sphingomyelinase Deficiency Overview

Acid sphingomyelinase deficiency (ASMD) is a rare progressive genetic disorder, caused by the mutations in the SMPD1 gene and is inherited in an autosomal recessive manner. Any mutation in the gene, leads to the production of a faulty protein and deficiency of the enzyme acidsphingomyelinase, required to break down a fatty substance called sphingomyelin. Consequently, sphingomyelin and other substances accumulate in various tissues of the body and can affect many organ of the system including brain, liver, spleen, lung etc.

Acid Sphingomyelinase Deficiency Epidemiology Insights

ASMD has traditionally been broken down into two subgroups – neuronopathic (type A) and non-neuronopathic (type B). Neuronopathic refers to disorders that damage brain cells (neurons). Type A generally causes severe neurodegenerative disease during infancy, while type B is generally not considered to be a neurologic disease. However, since cases fall in between these two extremes, an intermediate form, type A/B can also be seen. The main cause of ASMD is mutation in the sphingomyelin phosphodiesterase-1 (SMPD1) gene. Genes provide instructions for creating proteins that play a critical role in many body functions. When a gene mutation occurs, the protein product may be faulty, inefficient, or absent. Depending upon the functions of the particular protein, this can affect many organ systems of the body, including the brain.

Acid Sphingomyelinase Deficiency Epidemiology Segmentation in the 7MM

  • Total Treated Cases
  • Total Diagnosed Prevalence Cases

Acid Sphingomyelinase Deficiency Treatment Market

There is a tremendous lack of effective supportive therapies (especially for the infantile cases), let alone curative ones with the severe infantile neurovisceral phenotype encountering death by 3 years of age. Although the other less severe forms have a normal lifespan but a certain section die prematurely due to respiratory insufficiency and liver disease. Statins form the mainstay of treatment regimen that is used to treat hyperlipidemia characterized by low-high-density lipoprotein (HDL) cholesterol in NPD Type B adult cases.

View Detailed Report of Acid Sphingomyelinase Deficiency market companies and pipeline therapies @ Acid Sphingomyelinase Deficiency Treatment Landscape

Acid Sphingomyelinase Deficiency Market Insights

NPD B and A/B is associated with a substantial burden for many patients, caused by the profoundly negative impact of its clinical manifestations on physical, mental and psychosocial well-being. However, published data regarding the impact of the disease on QoL and daily functioning are limited, mainly owing to the rarity and heterogeneity of the disease and the lack of adequate disease-specific instruments to measure QoL. Given the wide spectrum of NPD B phenotypes, including intermediate forms characterized by mild to severe neurologic defects in addition to visceral, skeletal and hematologic ASMD manifestations, a refinement of the ASMD classification system is needed. A more precise description of ASMD subpopulations may improve disease recognition at initial presentation and thus lead to more timely diagnoses.

Acid Sphingomyelinase Deficiency Emerging Therapies

  • Xenpozyme (Olipudase Alfa): Sanofi Genzyme (Japan)
  • Olipudase Alfa: Sanofi Genzyme (US, EU)

Acid Sphingomyelinase Deficiency Market Drivers

  • Incentives for rare diseases
  • Lack of competition in the ASMD market

Acid Sphingomyelinase Deficiency Market Barriers

  • Lack of patients in clinical trials
  • High cost of research

To know about more new drugs for Acid Sphingomyelinase Deficiency treatment visit @ Acid Sphingomyelinase Deficiency Market Forecast

Table of Content

  1. Key Insights
  2. Executive Summary
  3. Competitive Intelligence Analysis for Acid sphingomyelinase deficiency (ASMD)
  4. Acid sphingomyelinase deficiency (ASMD): Market Overview at a Glance
  5. Acid sphingomyelinase deficiency (ASMD): Disease Background and Overview
  6. Patient Journey
  7. Acid sphingomyelinase deficiency (ASMD) Epidemiology and Patient Population
  8. Treatment Algorithm, Current Treatment, and Medical Practices
  9. Acid sphingomyelinase deficiency (ASMD) Unmet Needs
  10. Key Endpoints of Acid sphingomyelinase deficiency (ASMD) Treatment
  11. Acid sphingomyelinase deficiency (ASMD) Marketed Products
  12. Acid sphingomyelinase deficiency (ASMD) Emerging Therapies
  13. Acid sphingomyelinase deficiency (ASMD): Seven Major Market Analysis
  14. Attribute analysis
  15. 7MM: Acid Sphingomyelinase Deficiency Market Outlook
  16. Access and Reimbursement Overview of Acid sphingomyelinase deficiency (ASMD)
  17. KOL Views
  18. Acid Sphingomyelinase Deficiency Market Drivers
  19. Acid Sphingomyelinase Deficiency Market Barriers
  20. Appendix
  21. DelveInsight Capabilities
  22. Disclaimer
  23. About DelveInsight

Get in touch with our Business executive @ Acid Sphingomyelinase Deficiency Market Drivers and Barriers

List of Top Selling Market Research Reports in 2023

Transient Ischemic Attack Market

DelveInsight’s Transient Ischemic Attack Market Insights, Epidemiology, and Market Forecast report delivers an in-depth understanding of the Transient Ischemic Attack forecasted epidemiology.

Surgical Sealant Market

DelveInsight’s ‘Surgical Sealant Tissue -Market Insights, Competitive Landscape and Market Forecast – 2027’ report delivers an in-depth understanding of Surgical Sealant Tissue Market.

Supraventricular Tachycardia Market

DelveInsight’s Supraventricular Tachycardia Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Supraventricular Tachycardia, historical and forecasted epidemiology as well as the Supraventricular Tachycardia market trends in 7MM.

Stem Cell Market

Stem Cell Market Research Report provides comprehensive insights into the Stem Cell Market Size, Share, Key Companies, Competitive Analysis as well as the Market Forecast.

Scoliosis Market

Scoliosis Market Insights, Epidemiology, Market Forecast report delivers an understanding of Scoliosis, historical and forecasted epidemiology as well as the Scoliosis market trends in 7MM.

Ranibizumab Biosimilars Insight

DelveInsight’s, “Ranibizumab– Biosimilar Insight, 2022” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in Ranibizumab Biosimilars landscape.

Pigment Epithelial Detachment Market

DelveInsight’s Pigment Epithelial Detachment Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Pigment Epithelial Detachment, historical and forecasted epidemiology as well as the Pigment Epithelial Detachment market trends in 7MM.

Percutaneous Arterial Closure Device Market

Percutaneous Arterial Closure Device Market Research Report provides comprehensive insights into the Percutaneous Arterial Closure Device Market Size, Share, Key Companies.

Pediatric Growth Hormone Deficiency PGHD Market

Pediatric Growth Hormone Deficiency Market Insights, Epidemiology, and Market Forecast report delivers an understanding of the Pediatric Growth Hormone Deficiency forecasted epidemiology.

Inflammatory Pain Market

Inflammatory Pain Market Insights, Epidemiology, and Market Forecast-2032 report deliver an understanding of the forecasted epidemiology, and the Inflammatory Pain market trends in 7MM.

Parry-Romberg Syndrome PRS Market

Parry-Romberg Syndrome PRS Market Insights, Epidemiology, and Market Forecast report delivers an understanding of the Parry-Romberg Syndrome PRS, historical and forecasted epidemiology.

Familial Lipoprotein Lipase Deficiency Market

DelveInsight’s Familial Lipoprotein Lipase Deficiency Market Insights, Epidemiology and Market Forecast – 2032 report provides the detailed overview of the disease and in depth.

Myotonic Dystrophy Market

DelveInsight’s Myotonic dystrophy Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Myotonic dystrophy.

Non-Muscle Invasive Bladder Cancer Market

DelveInsight’s Non-Muscle Invasive Bladder Cancer (NMIBC) Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Non-Muscle Invasive Bladder Cancer (NMIBC), historical and forecasted epidemiology as well as the Non-Muscle Invasive Bladder Cancer (NMIBC) market trends in 7MM.

Peripheral Nerve Repair Devices Market

DelveInsight’s ‘Peripheral Nerve Repair Devices -Market Insights, Competitive Landscape and Market Forecast – 2027’ report delivers an in-depth understanding.

Ranibizumab Biosimilars Market

DelveInsight’s, “Ranibizumab– Biosimilar Insight, 2022” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in Ranibizumab Biosimilars landscape.

Vascular Imaging Market

DelveInsight’s ‘Vascular Imaging Market -Market Insights, Competitive Landscape and Market Forecast – 2027’ report delivers an in-depth understanding of Vascular Imaging Market.

Ewing Sarcoma Market

Ewing Sarcoma Market report delivers an in-depth understanding of the Ewing Sarcoma, historical and forecasted epidemiology as well as the Ewing Sarcoma market trends in 7MM.

Kawasaki Disease Market

Kawasaki Disease Market Insights, Epidemiology, and Market Forecast-2032 report deliver an understanding of the Kawasaki Disease forecasted epidemiology Kawasaki Disease market trends in 7MM.

Partial Paralysis Market

DelveInsight’s Partial Paralysis Market Insights, Epidemiology, and Market Forecast report delivers an in-depth understanding of the Partial Paralysis, historical and forecasted epidemiology.

Pertussis Market

DelveInsight’s Pertussis Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding.

Digestive System Fistula Market

Digestive System Fistula Market Insights, Epidemiology, and Market Forecast-2032 report delivers an in-depth understanding of the Digestive System Fistula forecasted epidemiology.

Japan Healthcare Outlook

DelveInsight’s,“Japan Healthcare Outlook Report, 2022,” provides comprehensive insights about the healthcare scenario, regulatory policies and reimbursement landscape in Japan.

Pigment Epithelial Detachment Market

DelveInsight’s Pigment Epithelial Detachment Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Pigment Epithelial Detachment, historical and forecasted epidemiology as well as the Pigment Epithelial Detachment market trends in 7MM.

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

Contact Us

Yash Bhardwaj

info@delveinsight.com

Newsmantraa